Comparison of the results from two different External Quality Assessment Schemes supports the utility of robust quality specifications

Clinical Chemistry and Laboratory Medicine

Volumn 49, Issue 7, 2011, Pages 1143-1149

  Carobene, Anna ^a,b   Franzini, Carlo ^c   Ceriotti, Ferruccio ^a,b  

^a PROLARIT   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

analytical quality; biological variation; external quality assessment; quality specifications

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMYLASE; BILIRUBIN; CHLORIDE; CHOLESTEROL; CREATININE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IRON; LACTATE DEHYDROGENASE; OROSOMUCOID; PHOSPHATE; POTASSIUM; PROTEIN; SODIUM; TRANSFERRIN; URATE; UREA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; AMYLASE BLOOD LEVEL; ARTICLE; ASSAY; BILIRUBIN BLOOD LEVEL; CHLORIDE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEALTH PROGRAM; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IRON BLOOD LEVEL; ITALY; LABORATORY; LACTATE DEHYDROGENASE BLOOD LEVEL; MANAGEMENT; PERFORMANCE; PHOSPHATE BLOOD LEVEL; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SODIUM BLOOD LEVEL; TRANSFERRIN BLOOD LEVEL; UREA BLOOD LEVEL; URIC ACID BLOOD LEVEL;

CLINICAL CHEMISTRY TESTS; HUMANS; QUALITY CONTROL;

EID: 79960221325     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2011.196     Document Type: Article

References (22)

1. Uldall A. Origin of EQA programmes and multidisciplinary cooperation between EQA programme organizer within laboratory medicine. EQA News 1997;8:1-27
2. International Organization for Standardization. Conformity assessment - General requirements for proficiency testing. ISO 17043. Geneva 2008
3. Fraser CG, Hyltoft Petersen P. Analytical performance characteristics should be judged against objective quality specifications wEditorialx. Clin Chem 1999;45:321-3 (Pubitemid 29114165)
4. Fuentes-Arderiu X, Miró-Balagué J. State of the art instead of biological variation to set requirements for imprecision wLetterx. Clin Chem 2000;46:1715-6
5. CDC. Current CLIA regulations (including all changes through 01/24/2004). http://www.cdc.gov/clia/regs/toc.aspx (Accessed September 2009)
6. Klee GG. Establishment of outcome-related analytic performance goal. Clin Chem 2010;56:714-22
7. Borsotti M, Quercioli M, Franzini C. Criteria for selecting limits for the acceptability of results in EQA schemes. Biochim Clin 2008;32:260-8
8. Westgard JO. Managing quality vs. measuring uncertainty in the medical laboratory. Clin Chem Lab Med 2010;48:31-40
9. Panteghini M. Application of traceability concepts to analytical quality control may reconcile total error with uncertainty of measurement. Clin Chem Lab Med 2010;48:7-10
10. Dighe AS, Rao A, Coakley AB, Lewandrowski KB. Analysis of laboratory critical value reporting at a large academic medical centre. Am J Clin Pathol 2006;125:758-64
11. American Diabetes Association. Diagnosis and classification of Diabetes Mellitus. Diabetes Care 2009;32(Suppl 1):S62-7
12. Grossi E, Colombo R, Cavuto S, Franzini C. The realab project: a new method for the formulation of reference intervals based on current data. Clin Chem 2005;51:1232-40 (Pubitemid 43079402)
13. Ceriotti F, Boyd JC, Klein G, Henny J, Queraltó J, Kairisto V, et al on behalf of the IFCC Committee on Reference Intervals and Decision Limits (C-RIDL). Reference intervals for serum creatinine concentrations: assessment of available data for global application. Clin Chem 2008;54:559-66 (Pubitemid 351359026)
14. Schumann G, Klauke R. New IFCC reference procedure for the determination of catalytic activity concentrations of five enzymes in serum: preliminary upper reference limits obtained in hospitalized subjects. Clin Chim Acta 2003;327:69-79 (Pubitemid 35447818)
15. De Backer G. New European guidelines for cardiovascular disease prevention in clinical practice. Clin Chem Lab Med 2009;47:138-42
16. Myron Johnson A. Amino acids, peptides, and proteins. In: Burtis CA, Edwards R, Ashwood ER, Bruns DE, editors. Tietz textbook of clinical chemistry and molecular diagnostics, 4th ed. St. Louis: Elsevier Saunders 2006:533-95
17. Biological variation database, and quality specifications for imprecision, bias and total error. The 2008 update. http://www.westgard.com/ guest.36htm. Accessed July 2010
18. Miller WG, Mayers GL, Rej R. Why commutability matters. Clin Chem 2006;52:553-4
19. Franzini C, Ceriotti F. Impact of reference materials on accuracy in clinical chemistry. Clin Biochem 1998;31:449-57 (Pubitemid 28391884)
20. Ricos C, Alvarez V, Cava F, Garcia-Lario JV, Hernandez A, Jimenez CV, et al. Integration of data derived from biological variation into the quality management system of medical laboratories. Accredit Qual Assur 2004;9:128-31 (Pubitemid 38376672)
21. http://www.westgard.com/rilibak.htm. Accessed 30 Jan 2011
22. Burnett D, Ceriotti F, Cooper G, Parvin C, Plebani M, Westgard J. Collective opinion paper on findings of the 2009 convocation of experts on quality control. Clin Chem Lab Med 2010: 48:41-52